# Galectin Therapeutics Inc: Form DEF 14A, filed Oct 22, 2025

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: DEF 14A
- Filed: 2025-10-22
- Accepted by EDGAR: Oct 22, 2025, 12:00 ET
- Period: 2025-12-03
- Accession: 0001140361-25-038875
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125038875/ny20055081x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036125038875/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036125038875/ny20055081x1_def14a.htm

Filed Oct 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-038875. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.